Anixa Biosciences Inc Quarterly Revenues in USD from Q2 2016 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Anixa Biosciences Inc annual/quarterly Revenues history and growth rate from Q2 2016 to Q1 2023.
  • Anixa Biosciences Inc Revenues for the quarter ending April 30, 2023 was $210K.
  • Anixa Biosciences Inc annual Revenues for 2024 was $210K, unchanged from 2023.
  • Anixa Biosciences Inc annual Revenues for 2023 was $210K.
  • Anixa Biosciences Inc annual Revenues for 2021 was $512K.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $210K Feb 1, 2023 Apr 30, 2023 10-Q 2023-06-14
Q4 2021 $513K +$500 +0.1% Nov 1, 2021 Jan 31, 2022 10-Q 2022-03-11
Q4 2020 $513K Nov 1, 2020 Jan 31, 2021 10-Q 2021-03-11
Q1 2019 $250K -$500K -66.7% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-09
Q2 2018 $363K $0 0% May 1, 2018 Jul 31, 2018 10-Q 2019-09-06
Q1 2018 $750K Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-12
Q2 2017 $363K +$263K +263% May 1, 2017 Jul 31, 2017 10-Q 2018-09-07
Q2 2016 $100K May 1, 2016 Jul 31, 2016 10-Q 2017-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.